Separately, the brand's site references published clinical-trial data for the drug class itself, stating that "tirzepatide and semaglutide have shown 15-20% body weight reduction in clinical trials." That figure describes the medication class in general clinical research - not Telos Rx's specific patient outcomes, and the two data points shouldn't be conflated
Soffritti S, Ricci G, Prete A, Rondelli R, Menna G, Pession A
MASLD, Metabolic Dysfunction-Associated Steatotic Liver Disease
While not a permanent fix for most concerns, the results from PRP therapy can last for several months
KPV: The Anti-Inflammatory Tripeptide From -MSH KPV is the quietest and least-studied of the four, and also the one whose evidence base is most clearly labeled preclinical only. It is a tripeptide lysine-proline-valine corresponding to the C-terminal three residues (positions 1113) of -melanocyte-stimulating hormone
The study reported changes in model-system outcomes under experimental conditions, but these findings remain limited to preclinical research and should not be interpreted as clinical conclusions